Cochran M, Coates P T H, Morris H A
Endocrine and Bone Center, Norwood, South Australia.
Clin Nephrol. 2005 Aug;64(2):98-102. doi: 10.5414/cnp64098.
Renal production of 1,25-dihydroxycholecalciferol is attenuated in early renal failure. Renal tubular reabsorption of calcium is diminished in moderate renal failure and we wished to see if this were true in the early stages and whether supplementary calcitriol would bring about correction. We were interested in the idea of 1,25-dihydroxycholecalciferol being a permissive agent, operating indirectly.
We measured calcium-related variables, including calculated ultrafiltrable serum calcium, before and after calcitriol 0.5 microg daily for six days in 34 subjects with stable mild renal failure.
The mean serum creatinine was 0.21 (+/- 0.08) mmol/l. The mean serum Ca++ was normal (1.18 mmol/l) but nine patients had values outside the normal range and in six cases, with low-normal serum Ca++ levels, there was a diminished tubular reabsorption. In five cases, basal serum Ca++ was mildly elevated. The coefficient of variation for serum Ca++ was 4.4%. PTH (1-84) levels were mildly elevated and 1,25-dihydroxycholecalciferol levels low-normal. The urine Ca/Cr, representing net bone resorption, was elevated in six cases. After calcitriol, the mean serum Ca++ level rose slightly and the coefficient of variation decreased to 3.6%. Changes in Ca++ whether upward or downward were accounted for by minor alterations in tubular reabsorption and a tendency to less net bone resorption. The initial Ca++ predicted (negatively) the magnitude of the correction. Neither the prevailing PTH nor the 1,25-dihydroxycholecalciferol levels explained any of the observed changes.
In early renal failure, there may be impaired regulation of serum Ca++. Despite elevated PTH, mild hypocalcemia may exist in the presence of increased net bone resorption relative to GFR. Hypocalcemia was accounted for by reduced renal tubular reabsorption of calcium which corrected after calcitriol. Net bone resorption tended to fall after calcitriol. Mild hypercalcemia, when present, was corrected by a reduction in tubular reabsorption. Calcitriol did not have a simple unidirectional effect but instead contributed to efficiency of the homeostatic mechanisms controlling the serum Ca++ set-point.
在早期肾衰竭时,肾脏生成1,25 - 二羟胆钙化醇的功能会减弱。在中度肾衰竭时,肾小管对钙的重吸收会减少,我们想了解在早期阶段是否也是如此,以及补充骨化三醇是否能纠正这种情况。我们对1,25 - 二羟胆钙化醇作为一种间接起作用的允许性因子的观点很感兴趣。
我们测量了34例稳定的轻度肾衰竭患者在每天服用0.5微克骨化三醇,持续六天前后的钙相关变量,包括计算得出的超滤血清钙。
平均血清肌酐为0.21(±0.08)毫摩尔/升。平均血清Ca++正常(1.18毫摩尔/升),但9例患者的值超出正常范围,在6例血清Ca++处于正常低限水平的病例中,肾小管重吸收减少。5例患者基础血清Ca++轻度升高。血清Ca++的变异系数为4.4%。甲状旁腺激素(1 - 84)水平轻度升高,1,25 - 二羟胆钙化醇水平处于正常低限。代表净骨吸收的尿Ca/Cr在6例患者中升高。服用骨化三醇后,平均血清Ca++水平略有上升,变异系数降至3.6%。Ca++的变化无论是上升还是下降,都是由肾小管重吸收的微小改变和净骨吸收减少的趋势所导致的。初始Ca++(呈负相关)可预测纠正的幅度。当时的甲状旁腺激素水平和1,25 - 二羟胆钙化醇水平均无法解释所观察到的任何变化。
在早期肾衰竭时,血清Ca++的调节可能受损。尽管甲状旁腺激素升高,但相对于肾小球滤过率,在净骨吸收增加的情况下可能存在轻度低钙血症。低钙血症是由肾小管对钙的重吸收减少所致,服用骨化三醇后得以纠正。服用骨化三醇后净骨吸收趋于下降。当存在轻度高钙血症时,通过肾小管重吸收的减少得以纠正。骨化三醇并非具有简单的单向作用,而是有助于控制血清Ca++设定点的稳态机制的效率。